The second extracellular loop of the prostaglandin EP3 receptor is an essential determinant of ligand selectivity

被引:51
作者
Audoly, L
Breyer, RM
机构
[1] VANDERBILT UNIV,SCH MED,DIV NEPHROL,NASHVILLE,TN 37232
[2] VANDERBILT UNIV,SCH MED,DEPT PHARMACOL,NASHVILLE,TN 37232
关键词
D O I
10.1074/jbc.272.21.13475
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The prostaglandin EP3 receptor binds Prostaglandin E-2 in a ligand binding pocket formed in part by seven transmembrane alpha-helices. The present studies demonstrate that the second extracellular loop of the receptor is involved in prostanoid ligand recognition as well. Site-directed mutagenesis of seven conserved residues clustered in the amino portion of the second extracellular loop was performed. Receptors with single amino acid substitutions at each of these positions were transiently transfected into HEK293tsA201 cells, their ligand binding profiles assessed, and each receptor was tested for its ability to decrease intracellular cAMP levels, Substitution of Trp(199) or Thr(202) with alanine resulted in receptors with increases in affinity up to 128-fold for prostanoid compounds with a C1 methyl ester but wild type affinities for natural prostanoid ligands that have a carboxylate moiety at the C1 position. In contrast, substitution of Pro(200) with serine caused a loss of selectivity up to 20-fold for naturally occurring prostanoid agonists as compared with the wild type EP3 receptor: the PS200 receptor displayed a decrease in affinity for E-ring compounds and an increase in affinity for F- and D-ring compounds. The EC50 for inhibition of cAMP remained unchanged for each receptor tested.
引用
收藏
页码:13475 / 13478
页数:4
相关论文
共 22 条
  • [1] AUDOLY L, 1997, MOL PHARMACOL, V57, P61
  • [2] STRUCTURE AND FUNCTION OF RECEPTORS COUPLED TO G-PROTEINS
    BALDWIN, JM
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1994, 6 (02) : 180 - 190
  • [3] Breyer MD, 1996, J AM SOC NEPHROL, V7, P8
  • [4] Cloning and expression of the rabbit prostaglandin EP(4) receptor
    Breyer, RM
    Davis, LS
    Nian, CL
    Redha, R
    Stillman, B
    Jacobson, HR
    Breyer, MD
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1996, 270 (03): : F485 - F493
  • [5] BREYER RM, 1994, J BIOL CHEM, V298, P6163
  • [6] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [7] TYR115 IS THE KEY RESIDUE FOR DETERMINING AGONIST SELECTIVITY IN THE V1A VASOPRESSIN RECEPTOR
    CHINI, B
    MOUILLAC, B
    ALA, Y
    BALESTRE, MN
    TRUMPPKALLMEYER, S
    HOFLACK, J
    ELANDS, J
    HIBERT, M
    MANNING, M
    JARD, S
    BARBERIS, C
    [J]. EMBO JOURNAL, 1995, 14 (10) : 2176 - 2182
  • [8] COLEMAN RA, 1994, PHARMACOL REV, V46, P205
  • [9] Mutagenic analysis of platelet thromboxane receptor cysteines - Roles in ligand binding and receptor-effector coupling
    DAngelo, DD
    Eubank, JJ
    Davis, MG
    Dorn, GW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) : 6233 - 6240
  • [10] THE EXTRACELLULAR DOMAIN OF THE NEUROKININ-1 RECEPTOR IS REQUIRED FOR HIGH-AFFINITY BINDING OF PEPTIDES
    FONG, TM
    YU, H
    HUANG, RRC
    STRADER, CD
    [J]. BIOCHEMISTRY, 1992, 31 (47) : 11806 - 11811